Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 19
Phase 25

Trial Status

Completed4
Recruiting1
Other5

Role Distribution

Other Roles10

Activity Timeline

Clinical Trials (10)

NCT02972528Phase 1/2Unknown
The Use of Allogenic Platelet Rich Plasma for the Treatment of Diabetic Foot Ulcer
Diabetic Foot Ulcer
StudydirectorStart date: 2018-02-03
NCT03326505Phase 1/2Completed
Allogenic Mesenchymal Stem Cells And Physical Therapy for MS Treatment
Multiple Sclerosis
StudydirectorStart date: 2017-09-25
NCT02940418Phase 1Unknown
Use of Stem Cells in Diabetes Mellitus Type 1
Diabetes Mellitus Type 1
StudydirectorStart date: 2017-02-19
NCT02979912Phase 1/2Completed
Autologous Platelet Lysate in Corneal Epithelial Defects
Persistent Corneal Epithelial Defect
StudydirectorStart date: 2017-02-16
NCT02963727Phase 1Unknown
Use of Wharton Jelly Derived Mesenchymal Stem Cells for Knee Osteoarthrosis
Knee Osteoarthrosis
StudydirectorStart date: 2017-01-27
NCT02966951Phase 1Unknown
Use of Adipose Tissue Derived Mesenchymal Stem Cells for Knee Osteoarthrosis
Knee Osteoarthrosis
StudydirectorStart date: 2017-01-17
NCT02945449Phase 1Completed
Safety of Wharton Jelly in Erectile Dysfunction
Erectile Dysfunction Associated With Type 2 Diabetes Mellitus
StudydirectorStart date: 2017-01-04
NCT02118519Phase 2Completed
Mesenchymal Stem Cells in Knee Cartilage Injuries
Articular Cartilage Disorder of KneeOsteoarthritis, Knee
Studydirector

Research Network

Collaboration Network

3 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Hiba Khalil, PhD

Al-Neelain University

Related
1 trials

Shared therapeutic areas:

Articular Cartilage Disorder of KneeOsteoarthritis, Knee

Worked with same sponsors:

University of Jordan
Collaborated on 1 trial
Similarity Score24%

Mahasen S Najjar, MD

Jordan University Hospital

Related
1 trials

Shared therapeutic areas:

Articular Cartilage Disorder of KneeOsteoarthritis, Knee

Worked with same sponsors:

University of Jordan
Collaborated on 1 trial
Similarity Score24%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Autistic DisorderMultiple SclerosisParkinson Disease
Similarity Score9%

Marie Carmen Valenza, phD

Universidad de Granada

Related
25 trials

Shared therapeutic areas:

Osteoarthritis, KneeMultiple SclerosisParkinson Disease
Similarity Score9%

Robert B Innis, M.D.

National Institute of Mental Health (NIMH)

Related
35 trials

Shared therapeutic areas:

Autistic DisorderMultiple SclerosisParkinson Disease
Similarity Score9%

Urielle Desalbres

Assistance Publique HĂ´pitaux de Marseille

Related
71 trials

Shared therapeutic areas:

Parkinson DiseaseDiabetes Mellitus, Type 1
Similarity Score6%

Nieto Luis, Master

Site Coordinator of United Medical Group located in Miami

Related
37 trials

Shared therapeutic areas:

Parkinson DiseaseAutistic Disorder
Similarity Score6%

Chadwick Prodromos, MD

The Foundation for Orthopaedics and Regenerative Medicine

Related
20 trials

Shared therapeutic areas:

Autistic DisorderMultiple Sclerosis
Similarity Score6%

Ken Nedd, M.D.

GAAD Medical Research Institute Inc.

Related
20 trials

Shared therapeutic areas:

Multiple SclerosisParkinson Disease
Similarity Score6%

Nieto Luis

Site Coordinator of United Medical Group

Related
23 trials

Shared therapeutic areas:

Autistic DisorderParkinson Disease
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (10)

Showing 10 of 10 trials

NCT06293950Phase 1StudyDirector

Allogeneic Wharton Jelly Mesenchymal Stromal Cell (WJMSC) for Treatment of Autism

Autism
Recruiting
NCT03684122Phase 1/2StudyDirector

Use of Mesenchymal Stem Cells (MSCs) Differentiated Into Neural Stem Cells (NSCs) in People With Parkinson's (PD).

Parkinson Disease
Unknown
NCT02972528Phase 1/2StudyDirector

The Use of Allogenic Platelet Rich Plasma for the Treatment of Diabetic Foot Ulcer

Diabetic Foot Ulcer
Unknown
NCT03326505Phase 1/2StudyDirector

Allogenic Mesenchymal Stem Cells And Physical Therapy for MS Treatment

Multiple Sclerosis
Completed
NCT02940418Phase 1StudyDirector

Use of Stem Cells in Diabetes Mellitus Type 1

Diabetes Mellitus Type 1
Unknown
NCT02979912Phase 1/2StudyDirector

Autologous Platelet Lysate in Corneal Epithelial Defects

Persistent Corneal Epithelial Defect
Completed
NCT02963727Phase 1StudyDirector

Use of Wharton Jelly Derived Mesenchymal Stem Cells for Knee Osteoarthrosis

Knee Osteoarthrosis
Unknown
NCT02966951Phase 1StudyDirector

Use of Adipose Tissue Derived Mesenchymal Stem Cells for Knee Osteoarthrosis

Knee Osteoarthrosis
Unknown
NCT02945449Phase 1StudyDirector

Safety of Wharton Jelly in Erectile Dysfunction

Erectile Dysfunction Associated With Type 2 Diabetes Mellitus
Completed
NCT02118519Phase 2StudyDirector

Mesenchymal Stem Cells in Knee Cartilage Injuries

Articular Cartilage Disorder of KneeOsteoarthritis, Knee
Completed

All 10 trials loaded